Somalia vs Syrian Arab Republic: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Somalia
4.0%
in 2024
Syrian Arab Republic
2.9%
in 2024
Somalia rank
2nd
Syrian Arab Republic rank
6th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Somalia
- Syrian Arab Republic
How they compare
Somalia currently reports 4.0% against 2.9% in Syrian Arab Republic, a difference of 1.1%.
That makes Somalia's figure about 1.4 times Syrian Arab Republic's.
Across all 10 years both countries report, Somalia has been ahead every year.
Somalia ranks 2nd and Syrian Arab Republic ranks 6th of 246 countries.
Somalia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Somalia | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.4% | 3.5% | 2.9% | Somalia |
| 2020s | 4.4% | 3.4% | 1.0% | Somalia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Somalia or Syrian Arab Republic?
- Somalia, at 4.0% against 2.9% in Syrian Arab Republic as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Somalia and Syrian Arab Republic?
- 1.1%, with Somalia ahead.
- How many years of comparable data are there for Somalia and Syrian Arab Republic?
- 10 years are reported by both, from 2015 to 2024.
- How do Somalia and Syrian Arab Republic rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Somalia ranks 2nd and Syrian Arab Republic ranks 6th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.